A Mutation in the HLA-B*2705-Restricted NP383-391 Epitope Affects the Human Influenza A Virus-Specific Cytotoxic T-Lymphocyte Response In Vitro

ABSTRACT Viruses can exploit a variety of strategies to evade immune surveillance by cytotoxic T lymphocytes (CTL), including the acquisition of mutations in or adjacent to CTL epitopes. Recently, an amino acid substitution (R384G) in an HLA-B*2705-restricted CTL epitope in the influenza A virus nucleoprotein (nucleoprotein containing residues 383 to 391 [NP383-391]; SRYWAIRTR, where R is the residue that was mutated) was associated with escape from CTL-mediated immunity. The effect of this mutation on the in vitro influenza A virus-specific CTL response was studied. To this end, two influenza A viruses, one with and one without the NP383-391 epitope, were constructed by reverse genetics and designated influenza viruses A/NL/94-384R and A/NL/94-384G, respectively. The absence of the HLA-B*2705-restricted CTL epitope in influenza virus A/NL/94-384G was confirmed by using 51Cr release assays with a T-cell clone specific for the NP383-391 epitope. In addition, peripheral blood mononuclear cells (PBMC) stimulated with influenza virus A/NL/94-384G failed to recognize HLA-B*2705-positive target cells pulsed with the original NP383-391 peptide. The proportion of virus-specific CD8+ gamma interferon (IFN-γ)-positive T cells in in vitro-stimulated PBMC was determined by intracellular IFN-γ staining after restimulation with virus-infected autologous B-lymphoblastoid cell lines and C1R cell lines expressing only HLA-B*2705. The proportion of virus-specific CD8+ T cells was lower in PBMC stimulated in vitro with influenza virus A/NL/94-384G obtained from several HLA-B*2705-positive donors than in PBMC stimulated with influenza virus A/NL/94-384R. This finding indicated that amino acid variations in CTL epitopes can affect the virus-specific CTL response and that the NP383-391 epitope is the most important HLA-B*2705-restricted epitope in the nucleoprotein of influenza A viruses.

[1]  A. Osterhaus,et al.  Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. , 2004, Virus research.

[2]  A. Osterhaus,et al.  Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. , 2004, Virus research.

[3]  J. Gog,et al.  Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Webster,et al.  Protection and compensation in the influenza virus-specific CD8+ T cell response , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Osterhaus,et al.  Influenza A virus specific T cell immunity in humans during aging. , 2002, Virology.

[6]  A. Osterhaus,et al.  Sequence Variation in a Newly Identified HLA-B35-Restricted Epitope in the Influenza A Virus Nucleoprotein Associated with Escape from Cytotoxic T Lymphocytes , 2002, Journal of Virology.

[7]  A. Osterhaus,et al.  The Magnitude and Specificity of Influenza A Virus-Specific Cytotoxic T-Lymphocyte Responses in Humans Is Related to HLA-A and -B Phenotype , 2002, Journal of Virology.

[8]  J Goodman,et al.  The value of a database in surveillance and vaccine selection , 2001 .

[9]  G. Rimmelzwaan,et al.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B‐lymphoblastoid cells , 2001, Clinical and experimental immunology.

[10]  Michael Bunce,et al.  Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.

[11]  C. Sample,et al.  An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. , 2001, Blood.

[12]  A. Osterhaus,et al.  A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. , 2000, Vaccine.

[13]  A. Osterhaus,et al.  Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes , 2000, Journal of Virology.

[14]  D. Moskophidis,et al.  Viral Escape by Selection of Cytotoxic T Cell–Resistant Variants in Influenza a Virus Pneumonia , 2000, The Journal of experimental medicine.

[15]  A. Osterhaus,et al.  Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. , 1998, Journal of virological methods.

[16]  P. Klenerman,et al.  The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection , 1998, Journal of Molecular Medicine.

[17]  H. Ploegh,et al.  Inhibition of Major Histocompatibility Complex Class I Antigen Presentation in Pig and Primate Cells by Herpes Simplex Virus Type 1 and 2 ICP47 , 1998, Journal of Virology.

[18]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[19]  A. Sette,et al.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.

[20]  M. Oldstone How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. , 1997, Virology.

[21]  E. Wherry,et al.  Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. , 1997, Journal of immunology.

[22]  P. Klenerman,et al.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[24]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[25]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[26]  J. Burrows,et al.  Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution , 1996, Journal of virology.

[27]  F. Lemonnier,et al.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.

[28]  R. Zinkernagel,et al.  Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus , 1995, Journal of virology.

[29]  A. Hughes,et al.  Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Koup Virus escape from CTL recognition , 1994, The Journal of experimental medicine.

[31]  J. Levy,et al.  Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein , 1994, The Journal of experimental medicine.

[32]  A. Sette,et al.  Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope , 1994, The Journal of experimental medicine.

[33]  B. Moss,et al.  Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes. , 1994, The Journal of general virology.

[34]  A. Sette,et al.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.

[35]  S. Burrows,et al.  Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. , 1994, International immunology.

[36]  V. Levitsky,et al.  T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues , 1994, The Journal of experimental medicine.

[37]  M. Masucci,et al.  HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. , 1993, Science.

[38]  C. Rice,et al.  CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope , 1992, The Journal of experimental medicine.

[39]  S. Burrows,et al.  Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein‐Barr virus , 1992, European journal of immunology.

[40]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[41]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[42]  D. Nixon,et al.  Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. , 1990, International immunology.

[43]  F. Ennis,et al.  HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. , 1988, Journal of immunology.

[44]  A. McMichael,et al.  Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.

[45]  Z. Ruzsics,et al.  Subversion of host defense mechanisms by adenoviruses. , 2002, Current topics in microbiology and immunology.

[46]  R. Phillips,et al.  Escape of human immunodeficiency virus from immune control. , 1997, Annual review of immunology.